Dentsply Sirona Changes First Quarter Conference Call Date to May 10th
CHARLOTTE, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that its first quarter 2022...
Month: May 2022
Medicenna Announces New Clinical Data Showing Dose-Dependent Stimulation of Anti-Cancer Immune Cells with MDNA11 in the Phase 1/2 ABILITY Study
-- Levels of Ki67+ expression by CD8+T cells and NK cells increased by 17-fold and 10-fold, respectively, in the third...
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S....
Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results
MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and...
Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer
Imagene AI team Imagene Founders Jonathan Zalach, Dean Bitan and Shahar Porat, Chief Scientific Officer Dr. Nurit Paz-YaacovImagene's proprietary deep...
Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candidates to Endo Ventures Limited
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is...
Atsena Therapeutics Announces Presentations at ARVO 2022 Annual Meeting and ASGCT 25th Annual Meeting
Presentations to feature laterally spreading capsid for the treatment of X-linked retinoschisis and dual vector technology for the treatment of...
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering Conference
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell therapyFindings...
Better For You Wellness Enters Definitive Agreement to Acquire Mango Moi, LLC
BFYW is Expecting to Close First of Many Contemplated M&A TransactionsColumbus, Ohio--(Newsfile Corp. - May 2, 2022) - Better For...
Tinley’s Acquires 100% of Lakewood Libations, Inc.
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - May 2, 2022) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX:...
Vapotherm to Report First Quarter 2022 Financial Results
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and...
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
On Its Anniversary, the Inventor of Measure-through Motion and Low Perfusion™ Pulse Oximetry Introduces the First Health Watch to Offer...
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
Blue Spark Technologies Announces Appointment of John DeFord, Ph.D. to its Board of Directors
The new board member will provide extensive expertise to expand the TempTraq® remote patient monitoring platform CLEVELAND--(BUSINESS WIRE)--Blue Spark Technologies...
Skyway Capital Markets Advises SPAC on $85 Million Medical Technology Merger
TAMPA, Fla.--(BUSINESS WIRE)--Skyway Capital Markets, LLC (“Skyway”) is pleased to announce the merger of SeaStar Medical, Inc. (“SeaStar Medical”), a...
Extended SpagoPix Patent Protection in USA
LUND, SWEDEN / ACCESSWIRE / May 2, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical AB (publ) has received notice from the...
Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting
-- Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving Complete Healing within Four Weeks;...
Brain Cancer Canada funds Canada’s first genomics technology for rapid and precise brain tumour diagnostics
TORONTO, May 01, 2022 (GLOBE NEWSWIRE) -- Today marks the first day of Brain Cancer Awareness month. On this day...
Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May
New data highlights include: - Phase 3 open-label extension study data for growth hormone-deficient children treated for 2.5 years with TransConTM...
Total number of voting rights and share capital in GN Store Nord
In accordance with Section 32 of the Danish Capital Markets Act, GN Store Nord is required to publish the total...